| Autor: |
Storry, Jill R., Sausais, Laima, Kim Hue-Roye, Mudiwa, Flora, Ferre, Zennie, Blajchman, Morris A., Lublin, Douglas M., Bei-Wen Ma, Miquel, Juan F., Nervi, Flavio, Pereira, Jaime, Reid, Marion E., Hue-Roye, Kim, Ferrer, Zennie, Ma, Bei-Wen |
| Předmět: |
|
| Zdroj: |
Transfusion; Mar2003, Vol. 43 Issue 3, p340-344, 5p, 1 Chart |
| Abstrakt: |
Background: The Cromer blood group system consists of seven high-incidence and three low-incidence antigens carried on decay-accelerating factor (DAF). This report describes the identification and characterization of a new Cromer high-incidence antigen, named GUTI.Study Design and Methods: RT-PCR and sequence analysis were performed on cDNA prepared from a Chilean donor whose serum contained the alloantibody (anti-GUTI). Based on the observed point mutation, a PCR-RFLP assay using MaeII was developed. To map the epitope, DAF-deletion mutants were tested by immunoblotting with anti-GUTI.Results: Sequence analysis revealed a substitution of 719G>A in DAF in the proband. The proband's parents and two daughters were heterozygotes for 719G>A, one sister whose RBCs typed GUTI- was homozygous for 719A, and one sister had the wild-type DAF (719G). Seven additional heterozygote samples were identified among 214 Chileans. No heterozygotes were found in 197 New York donors. Analysis using DAF-deletion mutants showed the antigenic determinant to be within short consensus repeat (SCR) 4.Conclusion: This study describes a novel high- incidence antigen (GUTI) in the Cromer blood group system characterized by the amino acid arginine at position 206 in SCR4 of DAF. The GUTI-negative proband has a substitution mutation that predicts for histidine at this position. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text